Extended Data Table 2 RTOG-0539 prospective clinical trial cohort

From: Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma

  1. Baseline characteristic and Molecular Group assignment for cases from the RTOG-0539 prospective phase 2 clinical trial with molecular data used for analysis.
Back to article page